Particle News: Latest Epidermal growth factor receptor news

EGFR Inhibitors Show Promise Against Immunotherapy-Resistant NF1-Mutant Melanoma

A NYU Langone Health study uncovered a reliance on EGFR signaling in NF1-mutant tumors prompting early-phase trials of cetuximab plus afatinib.

Avelumab and Cetuximab Combo Quadruples Progression-Free Survival in Advanced cSCC

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

Zongertinib Achieves Breakthrough in Treating HER2-Mutant Lung Cancer

LUT014 Gel Shows Promise in Reducing Severe Rash from Colorectal Cancer Therapy